Commentary

Podcast

Pharma Pulse: CDC Delays Hepatitis B Vaccine Vote, Value-Based Care Improves Senior Access, and Takeda Tests Wind-Powered Shipping

This episode of Pharma Pulse covers the CDC’s decision to postpone changes to Hepatitis B vaccine guidance, new research showing value-based care improves visit frequency and consistency for seniors, and Takeda’s partnership with VELA to launch wind-powered transport for medicines.

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering a delay in a key vaccine policy decision, new insights into senior care, and an innovative approach to sustainable pharma logistics.

  • The CDC’s vaccine advisory committee has postponed a decision on updating Hepatitis B vaccine recommendations. The group had been considering changes to adult vaccination schedules, but members said more data and discussion are needed before moving forward. The delay reflects the complexities of balancing evolving clinical evidence with public health priorities, especially as hepatitis B remains a significant global health concern.
  • In other news, a new study highlights that seniors enrolled in value-based primary care models receive more frequent and consistent visits compared to those in traditional care. Researchers note that the increased engagement can improve management of chronic conditions and reduce hospitalizations. As policymakers push for better outcomes and cost efficiency, the findings underscore the potential of value-based care to reshape how older adults access and experience healthcare.
  • Lastly, in supply chain news, Takeda has partnered with VELA to introduce wind-powered shipping for medicines. The collaboration will use specialized cargo vessels designed to decrease use-related greenhouse gas emissions by up to 99% compared to air freight. The initiative reflects growing momentum toward sustainable logistics solutions as pharmaceutical companies look for innovative ways to reduce their environmental footprint without compromising reliability.

From vaccine policy delays to advances in senior care and greener supply chains, these stories show the range of challenges and opportunities shaping healthcare and pharma today.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on AudioboomSpotify, or iHeart.

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.